Wednesday, February 26, 2025 | 12:47 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Gradual volume growth, valuations to cap diagnostic majors' returns

Easing of pressure from predatory pricing and steady network expansion is boosting growth for diagnostics companies, say Abdulkader Puranwala and Nisha Shetty of ICICI Securities

CoSara bags licence to make Covid-19 test kits, says will price it low
Premium

They expect a 13-14 per cent annual sales growth over FY2024-27 for the two companies on the back of improved volumes.

Ram Prasad Sahu

Listen to This Article

Riding on the back of network expansion and steady pricing, organised diagnostic players delivered a 14 per cent sales growth in the June quarter. Strong operating leverage in the business drove a 151 basis points year-on-year (157 basis points on a sequential basis) expansion in margins to 28.7 per cent for the sector.

Easing of pressure from predatory pricing and steady network expansion is boosting growth for diagnostics companies, say Abdulkader Puranwala and Nisha Shetty of ICICI Securities.

Post the June quarter results, some brokerages have upgraded their earnings estimates for the larger players and this has reflected on the

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in